← Human Trials & Peer-Reviewed Studies
Exploring the Causal Relationship between Vitamin D Levels and Deficiency with the Risk of Cataract: A Mendelian Randomisation Study.
Plain-language guide to PMID 40695255 (2025): observational study of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 40695255
- Journal
- Ophthalmic research
- Year
- 2025
- Study type
- Observational Study
- Authors
- Hashimi M et al. (4 authors)
- DOI
- 10.1159/000545332
What This Study Did, in Plain Language
What Was Tested
This observational study looks at Vitamin D, K2, Magnesium and Zinc.
To assess causality, the researchers then performed both one-sample and two-sample Mendelian randomisation (MR) analyses.
In the two-sample MR, publicly available summary statistics for vitamin D levels and deficiency were used to investigate their relationship with cataract.
Why It Was Studied
Whilst this correlation has been well reported, there is a lack of causal evidence.
Who Took Part
PubMed indexes the participants as middle-aged adults, both men and women.
How the Study Was Run
The researchers first conducted an observational study using UK Biobank (UKBB) data to explore the correlation between vitamin D levels and deficiency with incident cataract.
In the one-sample MR the researchers used genetic risk scores (GRSs) reflecting a genetic predisposition to higher vitamin D levels and vitamin D deficiency, examining its association with incident cataract.
Sensitivity analyses used a UKBB meta-analysis for vitamin D in a two-sample MR and a gene-focused analysis using variants in genes with a known role in vitamin D metabolism.
What Was Measured
PubMed files the paper under topics including Cataract, Mendelian Randomization Analysis, Vitamin D Deficiency, Vitamin D, Risk Factors, United Kingdom and Genetic Predisposition to Disease.
The authors tagged it with the keywords Genetics, Lens transparency and Mendelian randomisation.
What This Means in Plain Language
This is an observational study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2025 (Ophthalmic research), a journal based in Switzerland.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.